Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 706843, 6 pages
http://dx.doi.org/10.1155/2015/706843
Research Article

High Serum IgG4 Concentrations in Patients with Hashimoto’s Thyroiditis

1Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland
2Department of Statistics and Medical Informatics, Medical University of Bialystok, 15-276 Bialystok, Poland
3Department of Nuclear Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland

Received 16 December 2014; Accepted 27 January 2015

Academic Editor: Alexander Schreiber

Copyright © 2015 Anna Popławska-Kita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Hashimoto, “Zur Kenntniss der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa),” Archiv für Klinische Chirurgie, vol. 97, pp. 219–248, 1912. View at Google Scholar
  2. I. M. Roitt, D. Doniach, P. N. Campbell, and et al, “Auto-antibodies in Hashimoto's disease (lymphadenoid goitre),” The Lancet, vol. 271, no. 6947, pp. 820–821, 1956. View at Google Scholar · View at Scopus
  3. M. F. Prummel, T. Strieder, and W. M. Wiersinga, “The environment and autoimmune thyroid diseases,” European Journal of Endocrinology, vol. 150, no. 5, pp. 605–618, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. G. S. Cooper and B. C. Stroehla, “The epidemiology of autoimmune diseases,” Autoimmunity Reviews, vol. 2, no. 3, pp. 119–125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. E. N. Pearce, A. P. Farwell, and L. E. Braverman, “Thyroiditis,” The New England Journal of Medicine, vol. 348, no. 26, pp. 2646–2655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Bjoro, J. Holmen, O. Krüger et al., “Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The health study of Nord-Trondelag (HUNT),” European Journal of Endocrinology, vol. 143, no. 5, pp. 639–647, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Hamano, S. Kawa, A. Horiuchi et al., “High serum IgG4 concentrations in patients with sclerosing pancreatitis,” The New England Journal of Medicine, vol. 344, no. 10, pp. 732–738, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Hamano, S. Kawa, Y. Ochi et al., “Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis,” The Lancet, vol. 359, no. 9315, pp. 1403–1404, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Zen, K. Harada, M. Sasaki et al., “IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?” The American Journal of Surgical Pathology, vol. 28, no. 9, pp. 1193–1203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Zen, T. Fujii, Y. Sato, S. Masuda, and Y. Nakanuma, “Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease,” Modern Pathology, vol. 20, no. 8, pp. 884–894, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Cheuk, H. K. L. Yuen, S. Y. Y. Chu, E. K. W. Chiu, L. K. Lam, and J. K. C. Chan, “Lymphadenopathy of IgG4-related sclerosing disease,” The American Journal of Surgical Pathology, vol. 32, no. 5, pp. 671–681, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Sato, K. Notohara, M. Kojima, K. Takata, Y. Masaki, and T. Yoshino, “IgG4-related disease: historical overview and pathology of hematological disorders,” Pathology International, vol. 60, no. 4, pp. 247–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Taniguchi, M. Ko, S. Seko et al., “Interstitial pneumonia associated with autoimmune pancreatitis,” Gut, vol. 53, no. 5, pp. 770–771, 2004. View at Google Scholar · View at Scopus
  14. Y. Zen, S. Kitagawa, H. Minato et al., “IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung,” Human Pathology, vol. 36, no. 7, pp. 710–717, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Sato, K.-I. Ohshima, K. Ichimura et al., “Ocular adnexal IgG4-related disease has uniform clinicopathology,” Pathology International, vol. 58, no. 8, pp. 465–470, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kitagawa, Y. Zen, K. Harada et al., “Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Küttner's tumor),” The American Journal of Surgical Pathology, vol. 29, no. 6, pp. 783–791, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-I. Takeda, J. Haratake, T. Kasai, C. Takaeda, and E. Takazakura, “IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis,” Nephrology Dialysis Transplantation, vol. 19, no. 2, pp. 474–476, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Kasashima, Y. Zen, A. Kawashima et al., “Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis,” The American Journal of Surgical Pathology, vol. 32, no. 2, pp. 197–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S.-K. Chan, W. Cheuk, K.-T. Chan, and J. K. C. Chan, “IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease,” The American Journal of Surgical Pathology, vol. 33, no. 8, pp. 1249–1252, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Komatsu, H. Hamano, Y. Ochi et al., “High prevalence of hypothyroidism in patients with autoimmune pancreatitis,” Digestive Diseases and Sciences, vol. 50, no. 6, pp. 1052–1057, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Masaki, N. Kurose, and H. Umehara, “IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century,” Journal of Clinical and Experimental Hematopathology, vol. 51, no. 1, pp. 13–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Khosroshahi and J. H. Stone, “A clinical overview of IgG4-related systemic disease,” Current Opinion in Rheumatology, vol. 23, no. 1, pp. 57–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. H. Stone, Y. Zen, and V. Deshpande, “IgG4-related disease,” The New England Journal of Medicine, vol. 366, no. 6, pp. 539–551, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Kamisawa and A. Okamoto, “IgG4-related sclerosing disease,” World Journal of Gastroenterology, vol. 14, no. 25, pp. 3948–3955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Kamisawa, N. Funata, Y. Hayashi et al., “A new clinicopathological entity of IgG4-related autoimmune disease,” Journal of Gastroenterology, vol. 38, no. 10, pp. 982–984, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Zen and Y. Nakanuma, “IgG4-related disease: a cross-sectional study of 114 cases,” The American Journal of Surgical Pathology, vol. 34, no. 12, pp. 1812–1819, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Zhang, L. Zhao, Y. Gaeo et al., “A classification of Hashimoto's thyroiditis based on immunohistochemistry for IgG4 and IgG,” Thyroid, vol. 24, no. 2, pp. 364–370, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Deshpande, Y. Zen, J. K. C. Chan et al., “Consensus statement on the pathology of IgG4-related disease,” Modern Pathology, vol. 25, no. 9, pp. 1181–1192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Li, Y. Bai, Z. Liu et al., “Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis,” Pathology International, vol. 59, no. 9, pp. 636–641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Umehara, K. Okazaki, Y. Masaki et al., “Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD),” Modern Rheumatology, vol. 22, no. 1, pp. 21–30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Kakudo, Y. Li, E. Taniguchi et al., “IgG4-related disease of the thyroid glands,” Endocrine Journal, vol. 59, no. 4, pp. 273–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Li, E. Nishihara, M. Hirokawa, E. Taniguchi, A. Miyauchi, and K. Kakudo, “Distinct clinical, serological, and sonographic characteristics of Hashimoto's thyroiditis based with and without IgG4-positive plasma cells,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 3, pp. 1309–1317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Xu, X. Li, S. Chen et al., “Expression and distribution of S-100, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in tissues of thyroid carcinoma,” European Journal of Histochemistry, vol. 52, no. 3, pp. 153–162, 2008. View at Google Scholar · View at Scopus
  34. A. Bossowski, B. Czarnocka, K. Bardadin et al., “Identification of apoptotic proteins in thyroid gland from patients with Grave's desease and Hashimoto's thyroiditis,” Autoimmunity, vol. 41, no. 2, pp. 163–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Stojanović, D. Srefanović, D. Vulović, L. Puskas, and L. Marković, “Role of apoptosis in pathogenesis of thyroiditis,” Medicinski Pregled, vol. 62, no. 1-2, pp. 49–52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. O. Hengartner, “The biochemistry of apoptosis,” Nature, vol. 407, no. 6805, pp. 770–776, 2000. View at Google Scholar
  37. G. Bona, S. Defranco, A. Chiocchetti et al., “Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diseases,” Clinical and Experimental Immunology, vol. 133, no. 3, pp. 430–437, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. B. B. Ganesh, P. Bhattacharya, A. Gopisetty, and B. S. Prabhakar, “Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity,” Journal of Interferon and Cytokine Research, vol. 31, no. 10, pp. 721–731, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Pećina-Šlaus, “Genetic and molecular insights into apoptosis,” Acta Medica Croatica, vol. 63, supplement 2, pp. 13–19, 2009. View at Google Scholar · View at Scopus
  40. H. Wajant, J. Gerspach, and K. Pfizenmaier, “Tumor therapeutics by design: targeting and activation of death receptors,” Cytokine & Growth Factor Reviews, vol. 16, no. 1, pp. 55–76, 2005. View at Publisher · View at Google Scholar · View at Scopus